Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nocturnal oxygen for PH or ILD at altitude
NCT02150616Phase 4Unknown
- Sponsor
- University of Zurich
- Start
- May 2014
- Primary completion
- Dec 2020
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of oxygen in precapillary pulmonary hypertension, interstitial lung disease (ILD), sponsored by University of Zurich. Status: unknown.
02
Drugs
oxygen
03
Conditions
precapillary pulmonary hypertensioninterstitial lung disease (ILD)
Beyond the preview
Go deeper on NCT02150616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02150616.